Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes.

Authors:
Soliman O; Wilde DC; Kemnade JO; Sabichi AL; Chen G and 5 more

Journal:
Laryngoscope Investig Otolaryngol

Publication Year: 2023

DOI:
10.1002/lio2.1115

PMCID:
PMC10446265

PMID:
37621289

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Laryngoscope Investig Otolaryngol

Abbreviation: Laryngoscope Investig Otolaryngol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Otorhinolaryngology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
ACE2 and TAS2R38 receptor expression in pediatric and adult patients in the nasal and oral cavity.
Franks ZG; Nandakumar K; Santhanam L and 3 more (2024) - Transparency Score: 4/6
A comparative analysis of laryngeal nerve damage in patients with idiopathic vocal cord paralysis e…
Liu XH; Yan J; Li N and 8 more (2024) - Transparency Score: 3/6
A quantitative analysis of Twitter ("X") trends in the discussion of rhinoplasty.
Mandava S; Oyer SL; Park SS. (2024) - Transparency Score: 2/6
A response to a single cadaver study assessing the efficacy of two commercially available devices f…
Gould SJ. (2024) - Transparency Score: 3/6
Factors associated with successful electrolarynx use after total laryngectomy, a multi-institutiona…
Pan C; Andrews LIB; Johnson E and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors have no relevant conflicts of interest to disclose."

Evidence found in paper:

"FUNDING INFORMATION This work was supported by a Career Development Award to Vlad C. Sandulache from the Veterans Administration Clinical Science Research and Development division (1IK2CX001953)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025